Insider Trading activities of Opiant Pharmaceuticals, Inc. (OPNT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Opiant Pharmaceuticals, Inc. (OPNT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Opiant Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Opiant Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is OPNT. The reporting company's CIK number is 1385508.
The total value of stock buying since 2005 is $286,575.
The total value of stock sales since 2005 is $9,663,563.
The total value of stock option exercises since 2005 is $2,224,238.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Opiant Pharmaceuticals, Inc. (OPNT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-09 0 $0 70,000 $892,722 10,000 $90,000
2019-08 2,000 $30,660 10,000 $116,038 10,000 $90,000
2019-07 0 $0 10,000 $131,912 40,000 $390,000
2019-06 0 $0 10,000 $117,057 10,000 $90,000
2019-05 0 $0 10,000 $113,854 10,000 $90,000
2019-04 0 $0 60,000 $727,592 60,000 $452,499
2019-03 0 $0 10,000 $149,650 10,000 $90,000
2019-02 0 $0 10,000 $153,174 10,000 $90,000
2019-01 0 $0 60,000 $804,557 60,000 $431,473
2018-12 0 $0 4,321 $69,392 4,321 $38,889
2018-11 0 $0 5,038 $86,865 5,038 $45,342
2018-10 0 $0 34,075 $608,334 34,075 $255,405
2018-06 5,000 $83,015 0 $0 0 $0
2018-05 5,000 $90,450 7,063 $124,298 7,063 $70,630
2017-12 0 $0 211,224 $4,782,168 0 $0
2017-01 11,795 $82,450 0 $0 0 $0
2015-01 0 $0 1,700 $5,950 0 $0
2009-07 0 $0 10,000,000 $780,000 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Opiant Pharmaceuticals, Inc. insiders (OPNT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-09-12 Sinclair Michael Sale 60,000 12.52 751,200
2019-09-04 Skolnick Phil (Chief Scientific Officer) Sale 2,494 14.37 35,838
2019-09-03 Skolnick Phil (Chief Scientific Officer) Sale 7,506 14.08 105,684
2019-09-03 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-08-15 O'toole David D (Chief Financial Officer) Buy 1,000 15.20 15,200
2019-08-13 O'toole David D (Chief Financial Officer) Buy 1,000 15.46 15,460
2019-08-02 Skolnick Phil (Chief Scientific Officer) Sale 1,558 11.30 17,605
2019-08-01 Skolnick Phil (Chief Scientific Officer) Sale 8,442 11.66 98,433
2019-08-01 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-07-29 Ellison Mark Jason Heath Option Ex 30,000 10.00 300,000
2019-07-02 Skolnick Phil (Chief Scientific Officer) Sale 2,195 13.16 28,886
2019-07-01 Skolnick Phil (Chief Scientific Officer) Sale 7,805 13.20 103,026
2019-07-01 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-06-04 Skolnick Phil (Chief Scientific Officer) Sale 1,586 11.63 18,445
2019-06-03 Skolnick Phil (Chief Scientific Officer) Sale 8,414 11.72 98,612
2019-06-03 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-05-02 Skolnick Phil (Chief Scientific Officer) Sale 1,441 11.24 16,196
2019-05-01 Skolnick Phil (Chief Scientific Officer) Sale 8,559 11.41 97,658
2019-05-01 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-04-08 Crystal Roger (Chief Executive Officer) Sale 12,772 12.10 154,541
2019-04-05 Crystal Roger (Chief Executive Officer) Sale 16,001 11.98 191,691
2019-04-05 Crystal Roger (Chief Executive Officer) Option Ex 21,472 7.25 155,672
2019-04-04 Crystal Roger (Chief Executive Officer) Sale 16,836 11.93 200,853
2019-04-04 Crystal Roger (Chief Executive Officer) Option Ex 22,557 7.25 163,538
2019-04-03 Crystal Roger (Chief Executive Officer) Sale 3,791 12.24 46,401
2019-04-03 Crystal Roger (Chief Executive Officer) Option Ex 5,149 7.25 37,330
2019-04-02 Crystal Roger (Chief Executive Officer) Sale 600 12.48 7,488
2019-04-02 Crystal Roger (Chief Executive Officer) Option Ex 822 7.25 5,959
2019-04-02 Skolnick Phil (Chief Scientific Officer) Sale 2,007 12.47 25,027
2019-04-01 Skolnick Phil (Chief Scientific Officer) Sale 7,993 12.71 101,591
2019-04-01 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-03-01 Skolnick Phil (Chief Scientific Officer) Sale 10,000 14.96 149,650
2019-03-01 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-02-04 Skolnick Phil (Chief Scientific Officer) Sale 2,559 15.31 39,178
2019-02-01 Skolnick Phil (Chief Scientific Officer) Sale 7,441 15.32 113,996
2019-02-01 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2019-01-08 Crystal Roger (Chief Executive Officer) Sale 11,407 13.27 151,370
2019-01-07 Crystal Roger (Chief Executive Officer) Sale 26,759 13.28 355,359
2019-01-07 Crystal Roger (Chief Executive Officer) Option Ex 33,641 6.62 222,871
2019-01-04 Crystal Roger (Chief Executive Officer) Sale 11,834 13.54 160,232
2019-01-04 Crystal Roger (Chief Executive Officer) Option Ex 16,359 7.25 118,602
2019-01-04 Skolnick Phil (Chief Scientific Officer) Sale 2,232 13.48 30,087
2019-01-02 Skolnick Phil (Chief Scientific Officer) Sale 7,768 13.84 107,509
2019-01-02 Skolnick Phil (Chief Scientific Officer) Option Ex 10,000 9.00 90,000
2018-12-06 Skolnick Phil (Chief Scientific Officer) Sale 3,015 16.15 48,692
2018-12-03 Skolnick Phil (Chief Scientific Officer) Sale 1,306 15.85 20,700
2018-12-03 Skolnick Phil (Chief Scientific Officer) Option Ex 4,321 9.00 38,889
2018-11-06 Skolnick Phil (Chief Scientific Officer) Sale 3,217 16.81 54,077
2018-11-05 Skolnick Phil (Chief Scientific Officer) Sale 300 17.33 5,198
2018-11-01 Skolnick Phil (Chief Scientific Officer) Sale 1,521 18.14 27,590
2018-11-01 Skolnick Phil (Chief Scientific Officer) Option Ex 5,038 9.00 45,342
2018-10-09 Crystal Roger (Chief Executive Officer) Sale 6,941 17.04 118,274
2018-10-08 Crystal Roger (Chief Executive Officer) Sale 3,059 17.33 53,012
2018-10-05 Crystal Roger (Chief Executive Officer) Sale 847 18.14 15,364
2018-10-04 Crystal Roger (Chief Executive Officer) Sale 4,006 18.43 73,830
2018-10-04 Skolnick Phil (Chief Scientific Officer) Sale 1,845 18.43 34,003
2018-10-03 Crystal Roger (Chief Executive Officer) Sale 4,300 19.23 82,689
2018-10-03 Skolnick Phil (Chief Scientific Officer) Sale 1,500 19.23 28,837
2018-10-02 Crystal Roger (Chief Executive Officer) Sale 10,144 17.51 177,621
2018-10-02 Crystal Roger (Chief Executive Officer) Option Ex 29,297 7.25 212,403
2018-10-02 Skolnick Phil (Chief Scientific Officer) Sale 1,433 17.24 24,704
2018-10-02 Skolnick Phil (Chief Scientific Officer) Option Ex 4,778 9.00 43,002
2018-06-04 Macdougall Ann L. Buy 5,000 16.60 83,015
2018-05-18 Thomas Thomas T. Sale 500 16.50 8,250
2018-05-17 Thomas Thomas T. Sale 1,500 16.47 24,705
2018-05-16 Thomas Thomas T. Sale 763 16.29 12,429
2018-05-16 O'toole David D (Chief Financial Officer) Buy 2,000 16.95 33,900
2018-05-15 Thomas Thomas T. Sale 800 17.53 14,024
2018-05-14 Thomas Thomas T. Sale 3,500 18.54 64,890
2018-05-11 Thomas Thomas T. Option Ex 7,063 10.00 70,630
2018-05-11 O'toole David D (Chief Financial Officer) Buy 3,000 18.85 56,550
2017-12-28 Wolf Geoffrey Sale 43,000 22.52 968,360
2017-12-27 Wolf Geoffrey Sale 37,850 21.51 814,153
2017-12-21 Wolf Geoffrey Sale 20,000 24.17 483,400
2017-12-20 Wolf Geoffrey Sale 69,016 22.75 1,570,114
2017-12-19 Wolf Geoffrey Sale 3,850 19.69 75,806
2017-12-18 Wolf Geoffrey Sale 27,134 20.68 561,131
2017-12-13 Wolf Geoffrey Sale 7,804 29.61 231,076
2017-12-08 Wolf Geoffrey Sale 2,570 30.40 78,128
2017-01-17 Crystal Roger (Chief Executive Officer) Buy 3,475 6.99 24,290
2017-01-17 Sinclair Michael (Executive Chairman) Buy 3,500 7.00 24,517
2017-01-13 Pollack Kevin (See Remarks) Buy 4,820 6.98 33,643
2015-01-15 Sinclair Michael (Executive Chairman) Sale 1,700 3.50 5,950
2009-07-31 Meuse Joseph J (Director) Sale 10,000,000 .08 780,000

Insider trading activities including stock purchases, stock sales, and option exercises of OPNT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Opiant Pharmaceuticals, Inc. (symbol OPNT, CIK number 1385508) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month